Literature DB >> 30513056

A First Insight into the katG and rpoB Gene Mutations of Multidrug-Resistant Mycobacterium tuberculosis Strains from Ecuador.

Greta Franco-Sotomayor1, Daniel Garzon-Chavez2, Margarita Leon-Benitez1, Jacobus H de Waard3,4, Miguel Angel Garcia-Bereguiain3,5.   

Abstract

The aim of this study was to characterize the most frequent mutations associated with rifampicin (RIF) and isoniazid (INH) resistance of Mycobacterium tuberculosis isolates from Ecuador. Sequence analysis of 40 strains, resistant for the tuberculosis drugs INH, RIF, or for both showed that of the 31 strains with resistance to INH, 20 strains (64.5%) carried a mutation in the katG gene (codon 315). Eight INH-resistant strains carried a mutation in the katG gene at codon 463. This katG463 mutation, considered a phylogenetic marker, was exclusively found in INH-resistant strains and not in 121 INH-susceptible strains. Of the 35 strains resistant to RIF, 33 (93.9%) had mutations in the hot spot region of the rpoB gene, predominantly in codons 531, 516, and 526. Our results show that sequence-based detection for drug resistance of the katG will identify, respectively, 64.5% or, considering katG463 as a marker, 90.3% of the INH-resistant strains. Sequencing of the hot spot region of the rpoB gene will detect 94.3% of the RIF drug-resistant isolates in Ecuador. This is appropriate for fast screening for drug resistance with the GeneXpert MTB/RIF assay or by direct sequencing of a part of the genes katG and rpoB of PCR products obtained from DNA isolation from primary cultures.

Entities:  

Keywords:  Ecuador; isoniazid; rifampicin

Mesh:

Substances:

Year:  2018        PMID: 30513056     DOI: 10.1089/mdr.2018.0203

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  2 in total

1.  Fast, Simple, and Cheap: the Kudoh-Ogawa Swab Method as an Alternative to the Petroff-Lowenstein-Jensen Method for Culturing of Mycobacterium tuberculosis.

Authors:  Greta Franco-Sotomayor; Ismar A Rivera-Olivero; Margarita Leon-Benitez; Sandra E Uruchima-Campoverde; Greta Cardenas-Franco; Mercedes E Perdomo-Castro; Camilo S Cardenas-Franco; Jackeline Ortega-Vivanco; Ana S Abad-Ruiz; Jacobus H de Waard; Miguel Angel Garcia-Bereguiain
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

2.  A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB.

Authors:  Markus Beutler; Sara Plesnik; Marina Mihalic; Laura Olbrich; Norbert Heinrich; Samuel Schumacher; Michael Lindner; Ina Koch; Wolfgang Grasse; Christoph Metzger-Boddien; Sabine Hofmann-Thiel; Harald Hoffmann
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.